Eris Lifesciences share news, announcements and annual reports
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 3 Nov 2026. Previous close ₹1,160.20.
3 Nov: open ₹1,162.10, high ₹1,183.00, low ₹1,159.30
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,339 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.61%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,50,92584.8% delivered
Eris Lifesciences analyst meets
372 filed, newest first. Page 4 of 8.
Oct 2021
21 Oct · Analysts
Sep 2021
30 Sep · Analysts
29 Sep · Analysts
27 Sep · Analysts
21 Sep · Analysts
7 Sep · Analysts
6 Sep · Analysts
Aug 2021
26 Aug · Analysts
25 Aug · Analysts
24 Aug · Analysts
20 Aug · Analysts
19 Aug · Analysts
18 Aug · Analysts
12 Aug · Analysts
5 Aug · Analysts
Jul 2021
22 Jul · Analysts
21 Jul · Analysts
19 Jul · Analysts
6 Jul · Analysts
5 Jul · Analysts
2 Jul · Analysts
Jun 2021
29 Jun · Analysts
25 Jun · Analysts
24 Jun · Analysts
21 Jun · Analysts
15 Jun · Analysts
14 Jun · Analysts
10 Jun · Analysts
7 Jun · Analysts
2 Jun · Analysts
May 2021
31 May · Analysts
22 May · Analysts
10 May · Analysts
Mar 2021
10 Mar · Analysts
3 Mar · Analysts
3 Mar · Analysts
1 Mar · Analysts
Feb 2021
24 Feb · Analysts
23 Feb · Analysts
3 Feb · Analysts
2 Feb · Analysts
Jan 2021
25 Jan · Analysts
7 Jan · Analysts
Dec 2020
11 Dec · Analysts
7 Dec · Analysts
4 Dec · Analysts
3 Dec · Analysts
Nov 2020
11 Nov · Analysts
10 Nov · Analysts